Death due to high-output cardiac failure in fetal sacrococcygeal teratoma

Bond, Sheldon J.; Harrison, Michael R.; Schmidt, Klaus G.; Silverman, Norman H.; Flake, Alan W.; Slotnick, R. Nathan; Anderson, Robert L.; Warsof, Steven L.; Dyson, Donald C.

doi:10.1016/0022-3468(90)90535-h

Cited by 187 publications

(149 citation statements)

References 9 publications

Supporting

Mentioning

140

Contrasting

Unclassified

Order By: Relevance

“…In a series of 48 patients, these two criteria were the strongest predictors of fetal death. 11 Neither placentomegaly nor hydrops fetalis were present in our case, which appeared to imply a favorable prognosis for the newborn.…”

Section: Discussionmentioning

confidence: 48%

Fatal Rupture of a Sacrococcygeal Teratoma During Delivery

et al. 1999

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 48%

Fatal Rupture of a Sacrococcygeal Teratoma During Delivery

et al. 1999

View full text Add to dashboard Cite

“…Fetal anemia is the most common pathology in this category, and intrauterine transfusions, one of the first successful forms of invasive intrauterine intervention [101,102]. More recently, various groups have explored such therapy for less common lesions associated with high output states including arteriovenous malformations [103][104][105] and acardiac twin gestations [97,106]. From observations made in fetuses with arteriovenous MR1 formations, it has been suggested that when the fetal combined output exceeds nearly 2-fold the normal combined cardiac output the fetus may evolve hydrops or demise [107], an observation which may be applicable to other fetal high output states.…”

Section: Extracardiac Malformations With Cardiac Consequencesmentioning

confidence: 99%

Fetal Echocardiography and Prenatal Cardiovascular Interventions – An Update (2012)

Hornberger

Moon‐Grady²,

Tworetzky³

2012

J Clin Exp Cardiolog

View full text Add to dashboard Cite

Fetal echocardiography has evolved considerably over the past 1-2 decades into an exciting field that bridges maternal-fetal medicine with neonatology and pediatric cardiology. With significant advances in imaging technology and experience in prenatal diagnosis, details of the cardiac pathology can now be defined much as it is postnatally; however, unique aspects of the fetal circulation limit our ability to consistently define lesion severity and to predict the evolution of cardiac defects after birth. Serial assessment has provided an understanding of the antenatal natural history of fetal heart disease, which has led to improved counseling and perinatal/neonatal management strategies. More recently, this field has focused on improving our evaluation of fetal arrhythmias, exploring the pathophysiology of fetal heart failure, detecting heart defects at earlier gestational ages, identifying novel interventions to alter the development and progression of severe disease, and investigating strategies to optimize prenatal and neonatal care in an effort to improve perinatal outcome of affected pregnancies. In this paper we will review the current state of the art of fetal/perinatal cardiology and the advances that have occurred in the field largely over the past decade.

show abstract

“…If this were true then intervention to control this circulatory steal may be the only way to salvage severely aVected fetuses. 26 Close follow up with repeated ultrasound scans is necessary to monitor an increase in tumour size, extension into adjacent structures, tumour vascularity, and evidence of cardiac failure. 18 Volume reduction amniocentesis and tocolysis may be required to treat symptomatic polyhydramnios and prevent preterm delivery.…”

Section: Perinatal Managementmentioning

confidence: 99%